BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35909587)

  • 1. The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia.
    Wang W; Gu X; Shao L; Shi Z; Lou G; Song Z; Zhang Y
    Contrast Media Mol Imaging; 2022; 2022():2256690. PubMed ID: 35909587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of rhTPO and rhIL-11 in the treatment of chemotherapy-induced thrombocytopenia in hematological tumors based on real-world data.
    Zhang JJ; Zhao R; Xia F; Li Y; Wang RW; Guan X; Zhu JG; Ma AX
    Ann Palliat Med; 2022 Aug; 11(8):2709-2719. PubMed ID: 36064361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
    Xu YH; Chen ZW; Ye XY; Lu S
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
    Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Short-term intermittent prophylactic administration of recombinant human thrombopoietin attenuates chemotherapy-induced thrombocytopenia in lung cancer patients].
    Xu YH; Cheng BJ; Lu S; Jian H; Zhou Z; Chen ZW; Ye XY
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):395-9. PubMed ID: 21875475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Dai XF; Yu J; Liu L; Wu G
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):623-5. PubMed ID: 19102944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study.
    Chen M; Li L; Xia Q; Chen X; Liao Z; Wang C; Shen B; Zhou M; Zhang Q; Zhang Y; Qian L; Yuan X; Wang Z; Xue C; An X; Liu B; Gu K; Hou M; Wang X; Wang W; Li E; Zhong J; Cheng J; Shu Y; Yang N; Wang H; Yang R; Liu T; Deng T; Ma F; Liao W; Qiu W; Chen Y; Chen X; Zhang M; Xu R; Li X; Feng J; Ba Y; Shi Y
    Cancer; 2024 Apr; 130(S8):1524-1538. PubMed ID: 38515388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Consensus on clinical diagnosis, treatment and prevention management of chemotherapy induced thrombocytopenia in China(2018)].
    Consensus Committee of Chemotherapy Induced Thrombocytopenia, Chinese Society of Clinical Oncology
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):714-720. PubMed ID: 30293399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study.
    Liu Y; Jin G; Sun J; Wang X; Guo L
    Int J Infect Dis; 2020 Sep; 98():144-149. PubMed ID: 32561426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia.
    Vadhan-Raj S
    Semin Hematol; 2000 Apr; 37(2 Suppl 4):28-34. PubMed ID: 10831286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of recombinant human thrombopoietin in nonhuman primates with chemotherapy-induced thrombocytopenia.
    Akahori H; Shibuya K; Obuchi M; Nishizawa Y; Tsuji A; Kabaya K; Kusaka M; Ohashi H; Tsumura H; Kato T; Miyazaki H
    Br J Haematol; 1996 Sep; 94(4):722-8. PubMed ID: 8826901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human thrombopoietin improves platelet counts and reduces platelet transfusion possibility among patients with severe sepsis and thrombocytopenia: a prospective study.
    Wu Q; Ren J; Wu X; Wang G; Gu G; Liu S; Wu Y; Hu D; Zhao Y; Li J
    J Crit Care; 2014 Jun; 29(3):362-6. PubMed ID: 24405656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human thrombopoietin alleviates infection-associated thrombocytopenia: a retrospective study in senile patients.
    Lin J; Zhu H; Li S; Fan H; Lu X
    Clin Appl Thromb Hemost; 2015 Jan; 21(1):19-24. PubMed ID: 23637005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
    Vadhan-Raj S; Verschraegen CF; Bueso-Ramos C; Broxmeyer HE; Kudelkà AP; Freedman RS; Edwards CL; Gershenson D; Jones D; Ashby M; Kavanagh JJ
    Ann Intern Med; 2000 Mar; 132(5):364-8. PubMed ID: 10691586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human thrombopoietin in myelosuppressive chemotherapy.
    Vadhan-Raj S
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):35-8. PubMed ID: 11497230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia.
    Wang S; Yang R; Zou P; Hou M; Wu D; Shen Z; Lu X; Li Y; Chen X; Niu T; Sun H; Yu L; Wang Z; Zhang Y; Chang N; Zhang G; Zhao Y
    Int J Hematol; 2012 Aug; 96(2):222-8. PubMed ID: 22753022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial).
    Zhou Z; Feng T; Xie Y; Huang P; Xie H; Tian R; Qian B; Wang R
    BMC Infect Dis; 2019 Sep; 19(1):780. PubMed ID: 31492102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylactic recombinant human thrombopoietin treatment alleviates chemotherapy- induced thrombocytopenia in tumor patients].
    Li Q; Ye M; Xiao W; Zhu J; Zhang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1064-6. PubMed ID: 22820601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report: Heparin-induced thrombocytopenia associated with cardiopulmonary bypass: Preliminary attempt with recombinant human thrombopoietin therapy.
    Yuan SM
    Pak J Pharm Sci; 2015 Sep; 28(5):1793-6. PubMed ID: 26408899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.